Prosecutors accuse the Fort Worth cardiologist of assigning conditions such as hypertension and elevated blood pressure to student athletes who allegedly did not have them, thereby making standardized cardiovascular screenings appear medically necessary and eligible for insurance reimbursement.
WASHINGTON, DC, August 22, 2026 — Federal prosecutors allege that Doctor Jason Finkelstein submitted fabricated diagnoses for healthy student athletes, including hypertension and elevated blood pressure, to transform generally uncovered cardiovascular screenings into diagnostic procedures that insurers would reimburse.
The accusation places medical coding and patient records at the center of an $89 million healthcare fraud prosecution involving campus testing, nationwide physician licensing, traveling sonographers, remote result approvals, and approximately $13.1 million allegedly paid by healthcare benefit programs.
Finkelstein has pleaded not guilty to conspiracy and healthcare fraud charges, remains presumed innocent, and may require the government to prove that disputed diagnoses reflected intentional deception rather than coding mistakes, misunderstood athlete information, administrative practices, or legitimate clinical judgment.
Indictment describes diagnoses as a reimbursement mechanism
The federal indictment against Jason Finkelstein alleges that he and his co-conspirators submitted false diagnoses to insurers because healthcare benefit programs generally would not reimburse cardiovascular screening performed universally upon athletes without documented medical necessity.
Prosecutors claim conditions such as hypertension and elevated blood pressure were assigned to athletes who did not actually possess those conditions, creating a diagnostic justification for electrocardiograms, echocardiograms, and vascular ultrasound examinations performed during organized campus visits.
Under the government’s theory, the diagnoses were not incidental inaccuracies added after legitimate examinations, but essential representations designed to overcome coverage restrictions that otherwise prevented insurers from paying for broad preventive screening involving apparently healthy students.
That distinction will matter because an erroneous diagnosis can result from negligence, incomplete information, clerical confusion, software defaults, or disputed clinical interpretation, whereas criminal healthcare fraud requires proof of knowing and willful deception.
Healthy athletes allegedly received standardized testing
Prosecutors contend that almost every participating athlete received substantially the same package of six cardiovascular tests, despite meaningful differences in symptoms, medical history, family risk, prior examinations, athletic discipline, age, and recommendations from personal physicians.
A standardized screening protocol is not inherently fraudulent, particularly when schools and families worry about sudden cardiac arrest, but insurance coverage often depends on individualized clinical circumstances rather than the general preventive value of testing.
The government alleges that Finkelstein did not personally examine the athletes before the procedures, despite his identification as the ordering or referring physician on claims later submitted to commercial insurers and government-supported healthcare programs.
Defense attorneys may investigate whether questionnaires, trainer observations, remote consultations, medical histories, abnormal readings, family information, or other materials supplied a legitimate clinical basis for testing particular students without a traditional in-person examination.
Medical necessity allegedly created after recruitment
The prosecution’s narrative suggests that students were first recruited for predetermined campus testing packages and later linked to diagnoses that supported reimbursement, reversing the conventional sequence in which symptoms or clinical findings ordinarily lead physicians to specific diagnostic procedures.
If supported by authenticated records, that sequence could help prosecutors argue that medical necessity was constructed to fit services already scheduled for performance rather than determined independently through professional assessment of each athlete’s individual health circumstances.
The defense may dispute that characterization by presenting evidence that screening questionnaires identified risk factors, campus visits recorded elevated measurements, or physicians could lawfully establish medical necessity after reviewing information obtained through delegated clinical processes.
Jurors will therefore need to examine when diagnoses were entered, who selected them, what information existed beforehand, whether findings supported them, and how those conditions were communicated throughout medical records and insurance claims.
Blood-pressure conditions allegedly unlocked coverage
Hypertension and elevated blood pressure can provide clinical reasons for cardiovascular evaluation because persistent abnormal measurements may signal increased cardiac risk, possible organ effects, or a need for additional medical investigation and professional monitoring.
Prosecutors allege that participating athletes did not possess the reported conditions, making the diagnoses materially false representations rather than legitimate conclusions based upon documented readings, established histories, repeated measurements, or recognized diagnostic standards.
Insurance companies use diagnosis codes to evaluate whether billed procedures correspond with covered medical conditions, allowing automated claims systems and human reviewers to determine whether tests satisfy applicable medical-necessity policies and contractual reimbursement requirements.
A fabricated diagnosis can consequently influence payment even when the underlying examination was physically performed, because insurers may deny accurate claims for uncovered screening while approving otherwise identical procedures presented as responses to documented illness.
Coding records may identify who selected each condition
Electronic medical records and billing systems can preserve user names, entry times, amendments, diagnosis menus, copied templates, access histories, claim transmissions, and communications connecting particular individuals with conditions reported for particular athletes.
Prosecutors may combine those records with campus schedules and insurance data to demonstrate that identical diagnoses appeared repeatedly across geographically dispersed testing events, potentially supporting an inference that coding followed a centrally organized reimbursement strategy.
Defense lawyers can challenge whether accounts were shared, whether software automatically populated common diagnoses, whether coders acted independently, or whether incomplete audit logs inaccurately attribute administrative decisions directly to Finkelstein.
Because corporate medical operations divide responsibilities among physicians, technicians, coders, billers, managers, and outside vendors, the government must establish personal knowledge rather than assuming that professional ownership made Finkelstein aware of every diagnosis submitted.
Repeated patterns could support the government’s theory
A small number of inaccurate diagnoses might be explained through ordinary error, but prosecutors may argue that recurring conditions assigned across numerous athletes, campuses, insurers, and years demonstrate a deliberate system rather than isolated administrative failures.
Claims analysts could compare diagnosis frequencies within the testing population with those in ordinary athletic populations, using documented blood-pressure measurements, athlete questionnaires, campus medical files, and follow-up treatment to determine whether reported conditions had evidentiary support.
The defense may challenge statistical comparisons that ignore transient elevated readings, incomplete records, white-coat responses, family risk, different coding practices, or clinical information preserved outside the databases selected for government analysis.
Statistical anomalies can identify patterns warranting investigation, but they cannot independently prove that Finkelstein personally knew a diagnosis was false or intended that condition to influence a particular insurer’s payment decision.
Athlete testimony may test diagnostic accuracy
Former student athletes could testify about whether they had ever been diagnosed with hypertension, experienced relevant symptoms, disclosed abnormal readings, received medical consultations, or understood that testing would be submitted as treatment for specific conditions.
Some witnesses may say they believed the examinations were complimentary or school-sponsored screening rather than insured diagnostic care, potentially supporting the government’s contention that reported diagnoses did not originate from authentic patient encounters.
However, individual recollections years after brief campus events may be incomplete, particularly if young athletes had limited knowledge of billing terminology, electronic records, insurance submissions, or preliminary measurements recorded by testing personnel.
The defense could use medical histories, questionnaires, contemporaneous communications, and measurement records to challenge categorical claims that every athlete described as healthy lacked all clinical indications supporting further cardiovascular evaluation.
Schools may possess important contemporaneous evidence
Colleges and athletic departments may hold contracts, promotional materials, consent forms, appointment lists, invoices, trainer communications, insurance instructions, medical questionnaires, complaint records, and correspondence concerning the purposes represented for campus testing.
Those materials could reveal whether services were promoted as universal preventive screening, individualized diagnostic evaluation, insurance-covered medical care, or some combination that changed depending upon the audience receiving the explanation.
Prosecutors may contend that marketing emphasized potentially lifesaving screening while billing systems later described students as patients with diagnosed conditions, demonstrating a significant separation between public-facing recruitment and insurer-facing representations.
Defense attorneys may argue that marketing language does not define medical necessity, because conditions discovered or documented during an examination can lawfully support additional testing even when the original outreach emphasized preventive health.
Testing packages allegedly produced multiple claims
Traveling personnel allegedly performed electrocardiograms, echocardiograms, and several vascular ultrasound examinations upon participating students, allowing one campus encounter to generate multiple procedure claims when billed separately through professional associations associated with Finkelstein.
When repeated across groups of insured athletes at schools nationwide, a six-test package could produce considerable aggregate billing, particularly if diagnoses made every procedure appear responsive to recognized cardiovascular risk or disease.
The government alleges approximately $89 million in claims were submitted between 2019 and 2025, although that figure represents requested charges rather than money Finkelstein personally received or losses already established through judicial findings.
Healthcare benefit programs allegedly paid more than $13.1 million into accounts controlled by Finkelstein’s professional associations, while prosecutors separately claim that approximately $1.1 million reached him through checks and wire transfers containing reimbursement proceeds.
Three financial measurements remain distinct
The $89 million figure describes claims allegedly submitted, the $13.1 million figure describes payments allegedly made, and the approximately $1.1 million figure describes transfers prosecutors attribute personally to Finkelstein from accounts containing insurance reimbursements.
Maintaining those distinctions prevents aggregate billing from being inaccurately reported as personal profit, while still recognizing that prosecutors describe a substantial operation generating millions of dollars through claims they characterize as medically unsupported.
Defense accountants may separate legitimate revenue, operating expenses, professional compensation, disputed claims, and unrelated deposits, while government analysts may trace payments from particular insurers through corporate accounts toward alleged participants.
Even if inaccurate diagnoses are established, restitution and forfeiture would require additional legal and factual findings on causation, claim eligibility, legitimate value, ownership, tracing, attribution, and losses tied to proven criminal conduct.
Multiple insurers allegedly relied upon diagnosis information
The indictment identifies commercial insurance companies, the Federal Employees Health Benefits Program, the Veterans Health Administration, and joint federal-state Medicaid programs among the healthcare benefit programs allegedly billed for the student examinations.
Each payer may apply different medical-necessity rules, provider agreements, coding policies, documentation requirements, reimbursement schedules, appeal procedures, and definitions distinguishing preventive screening from covered diagnostic evaluation.
Prosecutors may call payer representatives to explain whether truthful descriptions of healthy athletes receiving standardized campus screening would have caused denials, reduced payments, requests for additional records, or coverage under different benefit provisions.
The defense can challenge broad assertions by requiring claim-specific evidence showing that each diagnosis was false, material under the relevant policy, transmitted with Finkelstein’s knowledge, and actually capable of influencing reimbursement.
Submitted diagnoses must be proved materially false
Healthcare fraud does not arise merely because a medical record contains an arguable diagnosis, since prosecutors must demonstrate a materially false or fraudulent representation made knowingly within a scheme intended to obtain healthcare benefit money.
A diagnosis may be clinically debatable without becoming fabricated, particularly when blood pressure fluctuates, measurements vary between environments, diagnostic thresholds require interpretation, or coding terminology differs from language familiar to patients.
The government will likely emphasize athletes whose records contain no abnormal readings, prior diagnoses, symptoms, family history, follow-up treatment, or other documentation that could support the conditions submitted to insurers.
Finkelstein’s attorneys may present experts who explain diagnostic discretion, coding conventions, temporary elevations, delegated information gathering, or circumstances under which further cardiovascular testing could remain medically appropriate despite an athlete’s outward health.
No personal examinations allegedly preceded testing
The government’s assertion that Finkelstein never personally examined participating athletes could matter because an individualized encounter might have generated symptoms, measurements, observations, or histories that supported the diagnoses used to order particular tests.
Nevertheless, modern medicine permits numerous remote and delegated processes, meaning physical separation alone does not establish that an ordering physician lacked adequate clinical information or failed to form a legitimate professional judgment.
Prosecutors must show how the actual workflow operated, including what Finkelstein received, when he reviewed it, what diagnoses appeared beforehand, and whether documentation was created merely to support claims after testing occurred.
The defense may argue that technicians, trainers, questionnaires, or electronic platforms supplied sufficient information, although jurors must determine whether those processes represented genuine clinical evaluation or administrative preparation for predetermined billing.
Rapid electronic approvals could reinforce intent allegations
Authorities allege that Finkelstein frequently approved large collections of cardiovascular results within seconds, presenting electronic timestamps as evidence that meaningful physician review did not occur before records were certified and claims were processed.
That alleged conduct may support the fabricated-diagnosis theory if prosecutors demonstrate that the same system rapidly converted standardized screening results into normal reports accompanied by unsupported conditions designed primarily to establish coverage.
Defense attorneys may respond that timestamps recorded only final signatures after earlier review, preliminary interpretations were available, normal studies required limited confirmation, or platform functions created misleading impressions about total professional review time.
Technology witnesses may explain account permissions, batch functions, audit histories, file organization, time zones, duplicated images, preliminary annotations, and the difference between opening a record and completing the full interpretive process.
One athlete’s death intensifies scrutiny
The indictment describes an athlete whose electronic file allegedly contained approximately 63 images and preliminary notations suggesting possible right-sided heart enlargement before Finkelstein reportedly approved the results as normal approximately eleven seconds after access.
That athlete died from sudden cardiac arrest while exercising with his basketball team approximately 24 days later, creating a devastating episode likely to receive careful attention during evidentiary hearings and any eventual trial.
Prosecutors may argue that the episode shows how an allegedly revenue-focused testing operation could generate diagnoses that support payment while overlooking an abnormality the screening purportedly existed to identify.
The defense may dispute image interpretation, preliminary notations, causation, preventability, or the meaning of electronic timestamps, while emphasizing that tragedy cannot replace proof of the knowledge and material deception required for healthcare fraud.
Fabricated illness allegations raise patient-record concerns
A false diagnosis can affect more than immediate reimbursement because medical information may follow patients into insurance records, future clinical encounters, eligibility reviews, athletic assessments, or applications requesting disclosure of significant health conditions.
Athletes who were allegedly described as hypertensive could have remained unaware that insurers received such information, particularly if campus communications presented the event as preventive screening and no clinician discussed a blood-pressure diagnosis afterward.
Prosecutors may use the absence of referrals, treatment plans, prescriptions, monitoring instructions, or follow-up recommendations to argue that company personnel did not genuinely believe the reported conditions existed.
The defense could answer that diagnostic codes sometimes identify symptoms, provisional concerns, or reimbursement categories without creating permanent clinical conclusions, making payer rules and individual record context essential to interpreting each entry.
Uncredentialed sonographers allegedly acquired images
Authorities also allege that some sonographers sent to campuses lacked requisite credentials, raising separate questions about technical competence, contractual compliance, professional supervision, image quality, and whether billed services were performed as represented.
The government may link personnel deficiencies to fabricated diagnoses by arguing that rapid nationwide expansion prioritized testing volume and reimbursement while bypassing individualized medical assessment and appropriate workforce credentialing.
Defense lawyers can require prosecutors to identify every worker, the allegedly missing credential, the applicable jurisdiction, the payer requirement, the examination performed, and the representation made, rather than allowing a generalized personnel allegation to characterize every campus event.
Even proven credentialing problems would not automatically establish Finkelstein’s knowledge or intent, although internal communications and hiring records could demonstrate whether company leaders recognized deficiencies and continued using affected personnel.
National licensing allegedly expanded the model
Finkelstein was reportedly licensed throughout the 48 contiguous states, allowing his professional identity to support orders, interpretations, and insurance claims involving athletes tested at campuses far beyond his Fort Worth practice.
Extensive licensing is lawful and may be used by physicians working through telemedicine or national networks, but prosecutors allege this footprint enabled standardized testing and fabricated diagnoses to reach multiple jurisdictions.
The government may examine when individual licenses were obtained, which school campaigns followed, how provider enrollment documents described the practice, and whether internal communications discussed licensing as a solution to reimbursement barriers.
The defense may present the portfolio as evidence that Finkelstein pursued regulatory compliance, requiring prosecutors to distinguish lawful professional preparation from an alleged agreement to submit medically unsupported claims.
Service locations were allegedly misrepresented
Prosecutors contend that claims sometimes indicated testing occurred at Finkelstein’s Texas office, although sonographers actually conducted examinations upon school campuses located in other states and transmitted materials electronically for review.
Service location can influence network status, reimbursement rates, supervision requirements, state authorization, facility eligibility, and payer evaluation, so an inaccurate address may be material even when the underlying test occurred.
The government may argue that Texas locations concealed the mobile campus operation and prevented insurers from assessing technician qualifications, physical facilities, patient encounters, and the true circumstances producing each diagnosis.
Defense counsel may attribute disputed locations to centralized billing conventions, professional-component rules, reassignment arrangements, software defaults, or clerical mistakes, requiring insurer-specific testimony about what each code represented and whether it affected payment.
Denied claims allegedly prompted false appeals
The indictment further alleges that Finkelstein and other participants submitted false documentation when appealing denied claims, suggesting disputed diagnoses and supporting records may have been defended after insurers questioned reimbursement eligibility.
Appeal files could become especially important because they may contain physician attestations, medical records, diagnosis explanations, service details, credential information, and direct answers to concerns raised by payer reviewers.
Prosecutors may argue that repeatedly defending unsupported diagnoses shows knowledge and intentional persistence, particularly if Finkelstein signed documents asserting that healthy athletes required the standardized cardiovascular procedures.
The defense may contend that billing employees or other participants prepared the appeal materials, that insurers misunderstood the services, or that contested submissions reflected legitimate advocacy in complicated coverage disputes.
Additional companies allegedly bypassed payer controls
Authorities accuse participants of creating additional companies to circumvent measures insurers implemented against suspected fraudulent billing and to conceal another alleged participant’s continuing involvement within the testing operation.
Corporate formation is lawful for many tax, liability, contracting, ownership, and operational reasons, so prosecutors must link restructuring to communications, provider applications, bank records, or other evidence showing a deceptive purpose.
A continuing pattern of identical diagnoses, campus testing packages, personnel, billing practices, and financial transfers across newly established entities could support the government’s contention that administrative changes were intended to preserve reimbursements.
Defense attorneys may argue that reorganizations addressed ordinary business needs or insurer disputes, insisting that company continuity cannot substitute for proof that Finkelstein knowingly fabricated medical conditions.
News reporting highlighted the diagnosis accusation
Associated Press reporting on the nationwide healthcare fraud crackdown described prosecutors’ claim that Finkelstein submitted diagnoses including elevated blood pressure and hypertension for athletes who did not possess those conditions.
The report situated his prosecution within a coordinated Justice Department initiative involving 455 defendants and more than $6.5 billion in alleged false claims, although accusations against unrelated defendants cannot establish evidence in Finkelstein’s case.
Public coverage emphasizing healthy athletes, fabricated illness, rapid approvals, and a student’s death may complicate jury selection, requiring careful procedures that separate admitted evidence from emotionally powerful allegations circulated before trial.
Neither news accounts nor government announcements constitute proof, and Finkelstein retains the right to confront witnesses, challenge records, present experts, dispute inferences, and require a unanimous verdict supported beyond a reasonable doubt.
Identity changes cannot erase medical accountability
The prosecution reflects principles discussed in Amicus International’s analysis of lawful identity-change myths, because changing a name, residence, citizenship, or lawful documentation cannot erase professional records, insurance claims, pending charges, or judicial obligations.
Similarly, Amicus International’s explanation of extradition procedures demonstrates why international relocation cannot lawfully obstruct federal proceedings, conceal forfeitable property, interfere with witnesses, defeat release conditions, or eliminate required courtroom appearances.
Nothing within the public indictment suggests that Finkelstein attempted to flee, change his identity, conceal his location, or evade prosecution, making these broader legal principles explanatory rather than allegations of additional misconduct.
The case instead demonstrates how physician licenses, payer enrollment files, diagnosis records, electronic signatures, corporate registrations, and banking transactions can preserve an interconnected professional history across numerous jurisdictions.
Prosecution must connect diagnoses with Finkelstein
The conspiracy count requires proof that Finkelstein knowingly and voluntarily joined an unlawful agreement to commit healthcare fraud or wire fraud, rather than merely associating with companies or individuals accused of misconduct.
The substantive healthcare fraud counts require transaction-specific evidence that he knowingly and willfully executed, or attempted to execute, a scheme using material deception to obtain money belonging to healthcare benefit programs.
Prosecutors may combine diagnosis patterns, ownership records, electronic access, rapid approvals, multistate licenses, claim appeals, internal messages, reimbursement deposits, and personal transfers to establish informed participation.
The defense may argue that marketers recruited athletes, technicians performed examinations, coders selected conditions, billers transmitted claims, and administrators managed appeals without Finkelstein knowing inaccurate diagnoses were attached.
Presumption of innocence remains controlling
An indictment records accusations approved for prosecution by a grand jury, but it does not establish that any athlete was healthy, any diagnosis was fabricated, any test was unnecessary, or any payment resulted from deception.
Finkelstein may challenge athlete testimony, coding records, payer policies, electronic audit logs, expert opinions, corporate attribution, financial tracing, government summaries, and testimony supplied by co-conspirators or former employees.
Prosecutors must prove guilt beyond a reasonable doubt, while the defense has no obligation to establish innocence or show that every diagnosis and business practice was appropriate.
Any discussion of restitution, forfeiture, professional discipline, or punishment remains premature unless convictions occur and later proceedings establish losses, proceeds, responsibility, and individualized legal consequences.
Trial will determine whether diagnoses were manufactured
At trial, jurors may hear from athletes, trainers, school officials, sonographers, coders, billers, company employees, insurers, medical experts, technology specialists, financial analysts, and federal investigators familiar with the disputed testing operation.
Their evidence may determine whether reported blood-pressure conditions arose from authentic clinical information, questionable coding practices, administrative confusion, or an organized effort to make uncovered screening appear reimbursable.
For prosecutors, the fabricated-diagnosis allegation provides a direct bridge connecting campus recruitment and standardized testing with claim payments, because the reported conditions allegedly supplied the medical necessity insurers required.
For the defense, the government must prove far more than unusual coding or aggressive screening: it must show that Finkelstein knew particular diagnoses were false and intentionally used them in a fraudulent reimbursement scheme.
Until authenticated evidence is presented, challenged through cross-examination, and evaluated under judicial instructions, the accusation that Jason Finkelstein fabricated diagnoses for healthy athletes remains an unproved prosecutorial allegation.
The eventual proceedings must determine whether hypertension and elevated blood pressure were genuine clinical assessments, provisional coding choices, mistakes made by others, or deliberately manufactured conditions designed to unlock millions of dollars in insurance payments.